The synergistic anti-asthmatic effects of glycyrrhizin and salbutamol

Acta Pharmacologica Sinica

Volumn 31, Issue 4, 2010, Pages 443-449

  Yang, Yang ^a,b   Shi, Qian ^a   Liu, Ze ^a   Li, Ruo Jie ^a   Pan, Peng Wei ^a   Hou, Yuan Yuan ^a   Lu, Wan Ge ^b   Bai, Gang ^a  

^a NANKAI UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

2 adrenergic receptor agonists; Asthma; Glucocorticoids; Glycyrrhizin; Salbutamol; Synergistic effects

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; GLYCYRRHIZIC ACID; MESSENGER RNA; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GUINEA PIG; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; TRACHEA;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CELL LINE; CYCLIC AMP; DRUG SYNERGISM; GLYCYRRHIZIC ACID; GUINEA PIGS; HUMANS; LUNG; MALE; NF-KAPPA B; RATS; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952125685     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.207     Document Type: Article

References (26)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-1745
2. Johnson M. Corticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 320-5; discussion 340-341
3. Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 268: L41-6.
4. Mak JC, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ. Protective effects of a glucocorticoid on downregulation of pulmonary beta2- adrenergic receptors in vivo. J Clin Invest 1995; 96: 99-106.
5. Adcock IM, Maneechotesuwan K, Usmani O. Molecular interactions between glucocorticoids and long-acting beta2-agonists. J Allergy Clin Immunol 2002; 110: S261-8.
6. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, et al. Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 2002; 26: 465-474
7. Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting beta2- adrenoceptor agonists synergistically enhance glucocorticoiddependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 2008; 73: 203-214
8. Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ, Yang CH, et al. Antiinflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol 2008; 154: 165-173
9. Ram A, Mabalirajan U, Das M, Bhattacharya I, Dinda AK, Gangal SV, et al. Glycyrrhizin alleviates experimental allergic asthma in mice. Int Immunopharmacol 2006; 6: 1468-1477
10. Harada S. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope. Biochem J 2005; 392: 191-199
11. -δ δCT method. Methods 2001; 25: 402-408
12. Bai G, Yang Y, Shi Q, Liu Z, Zhang Q, Zhu YY. Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist. Acta Pharmacol Sin 2008; 29: 1187-1194
13. Pomerantz JL, Denny EM, Baltimore D. CARD11 mediates factorspecific activation of NF-kappaB by the T cell receptor complex. EMBO J 2002; 21: 5184-5194
14. Vogel HG VW. Drug Discovery and Evaluation: Pharmacological Assay. 2nd ed. Springer-Verlag Berlin Heidelberg; 1997.
15. Takei H, Baba Y, Hisatsune A, Katsuki H, Miyata T, Yokomizo K, et al. Glycyrrhizin inhibits interleukin-8 production and nuclear factorkappaB activity in lung epithelial cells, but not through glucocorticoid receptors. J Pharmacol Sci 2008; 106: 460-468
16. Yoh T, Nakashima T, Sumida Y, Kakisaka Y, Nakajima Y, Ishikawa H, et al. Effects of glycyrrhizin on glucocorticoid signaling pathway in hepatocytes. Dig Dis Sci 2002; 47: 1775-1781
17. Barnes PJ, Adcock IM. Transcription factors and asthma. Eur Respir J 1998; 12: 221-234
18. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109: S81-96.
19. Fitzgerald DC, Meade KG, McEvoy AN, Lillis L, Murphy EP, Machugh DE, et al. Tumour necrosis factor-alpha (TNF-alpha) increases nuclear factor kappaB (NFkappaB) activity in and interleukin-8 (IL-8) release from bovine mammary epithelial cells. Vet Immunol Immunopathol 2007; 116: 59-68.
20. King EM, Holden NS, Gong W, Rider CF, Newton R. Inhibition of NFkappaB- dependent transcription by MKP-1: transcriptional repression by glucocorticoids occurring via p38 MAPK. J Biol Chem 2009; 284: 26803-26815
21. Johnson M. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 200-206
22. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009; 68: 1119-1124
23. Kobuke T, Inai K, Nambu S, Ohe K, Takemoto T, Matsuki K, et al. Tumorigenicity study of disodium glycyrrhizinate administered orally to mice. Food Chem Toxicol 1985; 23: 979-983 (Pubitemid 16202827)
24. Itami T, Ema M, Kanoh S. Effect of disodium glycyrrhizinate on pregnant rats and their offspring. J Food Hyg Soc Jpn 1985; 26: 460-464
25. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 2006; 46: 167-192
26. Lee CS, Kim YJ, Han ES. Glycyrrhizin protection against 3-morpholinosydnonime- induced mitochondrial dysfunction and cell death in lung epithelial cells. Life Sci 2007; 80: 1759-1767